May 24, 2012 TO: Marco Cavaleri CC: Hans-Georg Eichler European Medicines Agency 7 Westferry Circus- Canary Whar London E14 4 HB United Kingdom RE: Conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783) Dear Dr. Cavaleri, We wish to draw…
Research Funding Gaps Revealed Treatment Action Group has published two new reports on the crisis in national and international funding for scientific research on AIDS, tuberculosis (TB), and viral hepatitis. TB and hepatitis are diseases that affect hundreds of millions…
Recommendations submitted by Treatment Action Group to President Barack Obama on ways to strengthen the struggle to end AIDS Demonstrate Strong Domestic and Global Leadership TAG urges President Obama to make fighting AIDS a national and global priority through…
The Union Conference provides an important opportunity for TAG to exert its activist influence on all of the key people in the fight against TB. By Javid Syed The tuberculosis universe convenes once a year at the World Conference on…
International Advocacy Update By Claire Wingfield TPresentations from TAG’s recent meeting on universal access to TB and HIV treatment, care, and prevention as well as TAG ’s Funding Trends in TB R&D 2005–2007: A Preliminary Report, are available online. The…
Just Another Initiative? By Sue Perez Despite the constant uphill battle in getting its issues on the table and our concerns heard, civil society recognizes that the International Health Partnership presents opportunities. Launched in September 2007 by UK Prime Minister…
Battling the TB/HIV Epidemic through Community Action Through advocacy workshops and by coordinating and supporting activists' advocacy efforts, TAG and ICW work together to increase community understanding of TB/HIV coinfection and enhance research, treatment, and resources to combat the two…
By Theo Smart and Javid Syed A TAG-sponsored forum in South Africa brought together scientists, policy makers, and community activists to discuss multidrug resistant and extensively drug resistant TB and HIV and to identify steps to address the growing crisis…
By Theo Smart First published February 2, 2007 on AIDSmap.com. A large multicenter study conducted in Honduras and Brazil has shown that a new and relatively simple technique to detect active tuberculosis (TB), the microscopic observation drug susceptibility (MODS) test,…
By Theo Smart "You are more invested in the DOTS model -- which has failed [to contain] multidrug-resistant TB (MDR-TB) and which is now breeding extensively drug-resistant (XDR) TB -- than you are in saving lives," Mark Harrington, Executive Director…